Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Beijing Hospital of Traditional Chinese Medicine clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China and Japan registers with Beijing Hospital of Traditional Chinese Medicine as lead sponsor. Synced 18 Nov 2026
6Current trials
1Recruiting now
1Drug in these trials
2Trial registers
At a glance

Beijing Hospital of Traditional Chinese Medicine is the lead sponsor of 6 current clinical trials in our China and Japan registers. 1 is recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Carbamazepine. The most-studied condition is IBS, Diarrhea Predominant.

ClinicalTrials.gov trials by status

  • Recruiting117%
  • Not yet open583%

Trials by phase

  • Not applicable583%
  • Phase 3117%
01

Clinical trials sponsored by Beijing Hospital of Traditional Chinese Medicine

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
The Effects of the Yi Jin Jing on the Muscles and Bones of Adults
NCT07753291 · ClinicalTrials.gov ↗ · Musculoskeletal Health, Healthy Adult Volunteers
Not applicable Recruiting 2026-09 China
Yijinjing Exercise for Musculoskeletal Health in Adults With Sarcopenia
NCT07871240 · ClinicalTrials.gov ↗ · Sarcopenia
Not applicable Not yet open 2027-01 China, Japan
Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)
NCT07610434 · ClinicalTrials.gov ↗ · IBS, Diarrhea Predominant
Phase 3 Not yet open 2026-05 China
Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia
NCT07750730 · ClinicalTrials.gov ↗ · Trigeminal Neuralgia (TN)
Not applicable Not yet open 2026-08 China
Acupuncture for Painful Temporomandibular Disorder
NCT06738667 · ClinicalTrials.gov ↗ · Temporomandibular Disorders (TMD)
Not applicable Not yet open 2025-06 China
Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache
NCT07633522 · Chronic Migraine, Tension-type Headache
Not applicable Not yet open 2026-08 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Beijing Hospital of Traditional Chinese Medicine trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Beijing Hospital of Traditional Chinese Medicine trials

8 conditions
IBS, Diarrhea Predominant1Trigeminal Neuralgia (TN)1Sarcopenia1Musculoskeletal Health1Healthy Adult Volunteers1Temporomandibular Disorders (TMD)1Chronic Migraine1Tension-type Headache1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China61
Clinical trials in Japan10

A trial with sites in more than one country appears in each of those registers.

05

Questions about Beijing Hospital of Traditional Chinese Medicine trials

How many clinical trials does Beijing Hospital of Traditional Chinese Medicine sponsor?

Beijing Hospital of Traditional Chinese Medicine is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China and Japan registers, as of the registry sync on 18 November 2026. Completed and withdrawn studies are not counted.

Are Beijing Hospital of Traditional Chinese Medicine trials recruiting?

Yes. 1 of its 6 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Beijing Hospital of Traditional Chinese Medicine testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Carbamazepine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.